$CLDI

$0.64 -$0.00 (0.76%) Close

$CLDI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 2.6M shares outstanding

Who owns CLDI?

By type of holder

Institutions 20.3% Insiders 3.6% Everyone else 76.1%

Concentration Top 10 holders own 162.8%

Kessler Judd S 144.3% · Geode Capital Management, LLC 4.4%

Institutional ownership

20.3%

-57.4 pts vs last qtr

Institutional holders

-5 vs last qtr

Net shares bought

−1.5M

by institutions in Q2 2026

New / sold out

4 / 9

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Geode Capital Management, LLC +51.5K
Independent Advisor Alliance NEW +45.0K

Biggest sellers in Q2 2026

Armistice Capital, LLC SOLD OUT −879.0K
Sabby Management, LLC SOLD OUT −434.9K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Calidi Biotherapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+545.0%

+544.98% a year

Each share's claim on the business

−84.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $5.07M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years50% Under 1 year50%

Quarterly turnover

45.8%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting CLDI on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC Armistice Capital, LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding3.3M (Q1'25) Change over 8 quarters0 Armistice Capital, LLC's full portfolio →
SM Sabby Management, LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding434.9K (Q1'26) Change over 8 quarters0 Sabby Management, LLC's full portfolio →

Armistice Capital, LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

Sabby Management, LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

26 more super investors behind a free account

See every manager holding Calidi Biotherapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CLDI on Form N-PORT; together they hold 3.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$9.21K	49.8K	1.93%	0.00%	May 31, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$4.34K	25.5K	0.99%	0.00%	June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$9.21K

% of company

1.93%

% of the fund

0.00%

As of

May 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$4.34K

% of company

0.99%

% of the fund

0.00%

As of

June 30, 2026

4 more funds behind a free account

See every fund holding Calidi Biotherapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KJ Kessler Judd S 5%+ holder 13D · 5.0%	3.7M	144.33%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company144.330% Disclosed stake13D · 5.0% View the 13D/G filing →
LS Leftwich Scott Insider	43.6K	1.69%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.690% Leftwich Scott's insider activity →

Kessler Judd S

5%+ holder13D · 5.0%

3.7M

% of company

144.33%

Change vs last qtr

—

Held since

—

Leftwich Scott

Insider

43.6K

% of company

1.69%

Change vs last qtr

—

Held since

—

6 more holders behind a free account

See every insider and 5%+ holder of Calidi Biotherapeutics Inc.

Comments